Physician profile
John Ryan Taylor
NPI 1437418217
$10,057.31
in general payments reported to CMS, 2019-2025
16 companies · $1,499 in 2025
The $1,499 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,252 · 2020: $643 · 2021: $65.12 · 2022: $3,196 · 2023: $253 · 2024: $3,149 · 2025: $1,499.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,324 · Food and Beverage: $1,577.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,324.34 |
| Food and Beverage | $1,576.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Active Medical, LLC | $3,587.32 | 2020-2024 | |
| Stryker Corporation | $2,818.27 | 2020-2025 | Blueprint Patient Specific Instrumentation, Aequalis Perform, Alphavent |
| Arthrex, INC. | $1,199.68 | 2024 | |
| Wright Medical Technology, INC. | $894.38 | 2019 | |
| Paragon 28, INC. | $867.29 | 2022 | |
| Medical Device Business Services, INC. | $338.99 | 2019 | |
| Encore Medical, LP | $101.93 | 2022 | |
| Anika Therapeutics, INC. | $52.70 | 2022-2025 | Wristmotion, Integrity Implant |
| Vericel Corporation | $44.18 | 2022-2025 | Maci |
| Vertex Pharmaceuticals Incorporated | $29.84 | 2024 | |
| Globus Medical, INC. | $25.21 | 2023 | Proximal Humerus Strut |
| Pacira Pharmaceuticals Incorporated | $24.93 | 2025 | Exparel |
| Depuy Synthes Sales INC. | $18.70 | 2019 | |
| Ferring Pharmaceuticals INC. | $18.66 | 2023 | Euflexxa |
| Boston Scientific Corporation | $18.22 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.01 | 2023 | Relistor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.